Palo Alto, CA, United States of America

John L Krstenansky

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 2.0

ph-index = 11

Forward Citations = 491(Granted Patents)


Location History:

  • Mountain View, CA (US) (1993)
  • Cincinnati, OH (US) (1990 - 1999)
  • Palo Alto, CA (US) (1994 - 2000)

Company Filing History:


Years Active: 1990-2000

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Innovative Contributions of John L. Krstenansky

Introduction

John L. Krstenansky, based in Palo Alto, CA, is recognized for his remarkable contributions to the field of biochemistry and pharmacology. With an impressive portfolio of 24 patents, he has made significant strides in understanding and developing therapeutic agents, particularly in the realm of peptide analogs.

Latest Patents

Some of John’s latest inventions include novel analogs of parathyroid hormone and parathyroid hormone-related peptide. These innovative synthetic polypeptide analogs are designed to enhance the physiologically active properties of their natural counterparts. Notably, one of his patents involves amphipathic structures formed by the amino acid residues (22-31), specifically tailored to include both hydrophilic and lipophilic amino acids, optimizing their functionality. Additionally, he has developed anticoagulant peptides, which are valuable derivatives functioning as effective anticoagulant agents, thereby contributing to advancements in medical therapeutics.

Career Highlights

Throughout his career, John has collaborated with notable companies such as Syntex Inc. and Merrell Pharmaceuticals, Inc. His work within these organizations has been pivotal in translating innovative research into practical medical solutions. Many of his patents have laid the groundwork for important medications and therapeutic applications, showcasing his commitment to enhancing healthcare through science.

Collaborations

John has been privileged to work alongside esteemed colleagues, including John J. Nestor, Jr. and Brian H. Vickery. Their collaborations have fostered a creative environment, leading to significant breakthroughs in the development of peptide-based therapies. Together, they have shared knowledge and expertise, further driving innovation in their field.

Conclusion

John L. Krstenansky’s journey reflects a dedication to the pursuit of innovation in biochemistry and medicine. His prolific contributions, marked by 24 patents, highlight his role as a leading inventor in developing new therapeutic agents. Through his extensive collaborations and experience, John continues to make an impact that resonates within the scientific community, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…